CREST-UK: Real-world effectiveness, safety and outpatient delivery of CPX-351 for first-line treatment of newly diagnosed therapy-related AML and AML with myelodysplasia-related changes in the UK.

Autor: Mehta P; University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK., Campbell V; Western General Hospital, Edinburgh, UK., Maddox J; South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK., Floisand Y; Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK., Kalakonda AJM; Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK.; NIHR CRN North West Coast, Liverpool, UK., O'Nions J; University College London Hospitals NHS Foundation Trust, London, UK., Coats T; Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK., Nagumantry S; Peterborough City Hospital, Peterborough, UK., Hodgson K; University Hospitals of Leicester NHS Trust, Leicester, UK., Whitmill R; Royal Wolverhampton NHS Foundation Trust, Wolverhampton, UK., Amott I; University Hospitals Derby & Burton, NHS Foundation Trust, Derby, UK., Flynn G; Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, Portsmouth, UK., Taussig D; Haemato-Oncology Department, Royal Marsden Hospital, UK.; Institute of Cancer Research, London, UK., Zhao R; Torbay and South Devon NHS Foundation Trust, UK., Cunningham N; Belfast City Hospital, Belfast, UK., Roset M; IQVIA, Real World Solutions, Barcelona, Spain., Cuadras D; IQVIA, Real World Solutions, Barcelona, Spain., Medalla G; Jazz Pharmaceuticals, Oxford, UK., Kuter H; Jazz Pharmaceuticals, Oxford, UK., Park S; Jazz Pharmaceuticals, Oxford, UK., Legg A; Jazz Pharmaceuticals, Oxford, UK., Khan AB; Leeds Teaching Hospitals NHS Foundation Trust, Leeds, UK.

Publikováno v: British journal of haematology [Br J Haematol] 2024 Oct; Vol. 205 (4), pp. 1326-1336. Date of Electronic Publication: 2024 Jul 08.

SARS-CoV-2 vaccine responses following CD20-depletion treatment in patients with haematological and rheumatological disease: a West Midlands Research Consortium study.

Autor: Shields AM; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.; Department of Clinical Immunology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Venkatachalam S; Department of Rheumatology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK., Shafeek S; Department of Haematology, Worcestershire Acute NHS Trust, Worcester, UK., Paneesha S; Department of Haematology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Ford M; Department of Rheumatology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK., Sheeran T; Department of Rheumatology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK., Kelly M; Department of Haematology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Qureshi I; Department of Haematology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Salhan B; Department of Haematology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Karim F; Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK., De Silva N; Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK., Stones J; Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK., Lee S; Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK., Khawaja J; Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK., Kaudlay PK; Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK., Whitmill R; Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK., Kakepoto GN; Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK., Parry HM; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.; Department of Haematology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Moss P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.; Department of Haematology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Faustini SE; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Richter AG; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.; Department of Clinical Immunology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Drayson MT; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.; Department of Clinical Immunology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Basu S; Department of Haematology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK.; Faculty of Science & Engineering, University of Wolverhampton, Wolverhampton, UK.

Publikováno v: Clinical and experimental immunology [Clin Exp Immunol] 2022 Jan 28; Vol. 207 (1), pp. 3-10.

Clinical outcomes of pandemic (H1N1) 2009 influenza (swine flu) in adults with cystic fibrosis.

Autor: Nash EF, Whitmill R, Barker B, Rashid R, Whitehouse JL, Honeybourne D

Publikováno v: Thorax [Thorax] 2011 Mar; Vol. 66 (3), pp. 259. Date of Electronic Publication: 2010 Sep 06.

A study of factors associated with the pupil performance at two levels of cognition in world history

Autor: Whitmill, R. C

Publikováno v: IndraStra Global.

Not available

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=issn23813652::e4fbfba908e69960d7e8c5e0d5af552c
http://hdl.handle.net/2346/16976

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.